CClinicalTrials.gg
CompletedNCT05404152Updated Jul 5, 2022

Evaluation of Cognitive Impairment in the Elderly Admitted to Nursing Homes

An observational study in Neurocognitive Disorder, Etiology of Neurocognitive Disorder, sponsored by Universidad de Murcia. Completed at 1 site in Spain. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2022-07-05.

Sponsored by Universidad de Murcia · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
390
Ages
60 Years and older
Sex
All
01

Study summary

This research aims at analysing the profile of the elderly with cognitive impairment (IC) and inquiring about the mental illnesses that cause cognitive impairment of a population (elderly admitted to nursing homes with a high incidence).

Read the detailed description

The objectives of these studies are to determine the presence of IC and the profile of users who suffer from it in 8 nursing homes in the province of Pontevedra of new admission in 2017, as well as the identification of the frequency of underdiagnosis in the filiation of the mental pathology that causes IC and if that underdiagnosis is related to the presence of doctors or nurses specialists in geriatrics. Sociodemographic, clinical (with special relevance in cognitive assessment and the presence of mental disorders) and functional variables will be analyzed. In addition to providing information that can improve the DC early detection as well as the scarcity of studies in this field, the importance of this research is justified by developing treatment guidelines for people with IC in the future

02

Conditions studied

  • Neurocognitive Disorder, Etiology of Neurocognitive Disorder

Keywords

  • Cognitive impairment, nursing home, neurocognitive disorder
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,099 are open to participants now.

This study's enrollment of 390 is above the median of 150 across 950 observational studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Universidad de Murcia is the lead sponsor of 77 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

  • Elderly without cognitive assessment at admission
  • Existence of doubts about the presence of IC

Inclusion criteria

  • Vounteer
  • Elderly Admitted to Nursing homes
  • From 60 years old

Exclusion criteria

Exclusion Criteria:

  • Elderly without cognitive assessment at admission
  • Existence of doubts about the presence of IC
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
390 participants (actual)
Patient registry
No

Groups and cohorts

  • Ederly

    Elderly Admitted to Nursing homes

06

What researchers measure

Primary outcomes

  1. Study of Evaluation of Cognitive Impairment. MEC o MMSE <24 points or diagnosis of Neurocognitive disorder

    Time frame: Two years

Secondary outcomes

  1. Statistical correlation of CI with educational level.

    Time frame: Two years

Other outcomes

  1. Causes underdiagnosis of IC affiliation and Mental illnesses that cause IC

    Time frame: Two years

07

Study locations

1 site
  • UMurcia
    Murcia, Spain
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05404152
Lead sponsor
Universidad de Murcia
Responsible party
MARIA ELENA MOSQUERA LOSADA (Principal Investigator, Universidad de Murcia) — Principal investigator
First posted
Jun 3, 2022
Start date
Dec 31, 2021
Primary completion
Apr 1, 2022
Completion
May 1, 2022
Last update
Jul 5, 2022

Study contacts

MARIA ELENA MOSQUERA LOSADA, MSc in Nursing
principal investigator · Universidad de Murcia
ANTONIA GOMEZ-CONESA, PhD, PT
study director · Universidad de Murcia
RAMON GONZALEZ CABANACH, PhD
study director · University of A Coruña

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion